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Since 2011, human immunodeficiency virus (HIV) inci-
dence appears unchanged in the European Union/
European Economic Area with between 29,000 and 
33,000 new cases reported annually up to 2015. 
Despite evidence that HIV diagnosis is occurring earlier 
post-infection, the estimated number of people living 
with HIV (PLHIV) who were unaware of being infected 
in 2015 was 122,000, or 15% of all PLHIV (n=810,000). 
This is concerning as such individuals cannot benefit 
from highly effective treatment and may unknowingly 
sustain transmission.
Although preventable through effective public health 
measures, human immunodeficiency virus (HIV) per-
sists in the 31 countries of the European Union and 
European Economic Area (EU/EEA) [1]. In this report an 
analysis of EU/EEA HIV and acquired immunodeficiency 
syndrome (AIDS) surveillance data from 2015 as well 
as from prior years is presented. We estimate that, in 
2015, 15% (122,000/810,000) of people living with HIV 
(PLHIV) in the EU/EEA were unaware of their infection.
Analysis of annual surveillance data
HIV and AIDS surveillance data are reported annually 
by EU/EEA countries to a joint database for HIV/AIDS 
within the European Surveillance System (TESSy) coor-
dinated by the European Centre for Disease Prevention 
and Control (ECDC) and the World Health Organization 
(WHO) Regional Office for Europe [1]. 
Annual data on HIV diagnoses from 2003 to 2015 were 
stratified by the presence of a concurrent AIDS diagno-
sis, i.e. an AIDS-defining event within 3 months of HIV 
diagnosis, and, for individuals without AIDS, by CD4 
cell count (≥ 500, 350–499, 200–349, < 200 cells/mm3) 
at the time of diagnosis [2]. 
The ECDC HIV Modelling Tool version 1.2.2 was used to 
derive both the estimates of annual HIV incidences, as 
well as those of the average times from infection to HIV 
diagnosis each year [3]. These two types of estimates 
are only presented for the period from 2011 to 2015 due 
to greater uncertainty of data from the previous years 
of the study. 
The number of PLHIV in 2015 who were not yet diag-
nosed was obtained by fitting to data on HIV diagnoses 
from 2003 to 2011, adjusted for reporting delay, using 
the ‘Incidence Method’, a CD4 cell count-based back-
calculation method [4]. 
Data on the estimated number of diagnosed PLHIV were 
reported for 2015 by nominated contact points in EU/
EEA countries to ECDC as part of the Dublin Declaration 
monitoring process in 2016 [5]. In the three countries 
(Iceland, Liechtenstein, and Norway) not reporting 
estimates of diagnosed PLHIV, data on cumulative HIV 
cases reported to TESSy through 2015 minus the num-
ber of persons reported to have died, were used as a 
proxy for diagnosed PLHIV. 
The estimated number of diagnosed PLHIV from the 
Dublin Declaration monitoring reports and the undiag-
nosed PLHIV estimate from the model were summed 
to obtain the total number of PLHIV in the EU/EEA for 
2015. This was used to derive the proportion undiag-
nosed PLHIV in that year. 
Comparable estimates of the number of diagnosed 
PLHIV from the Dublin Declaration monitoring are not 
available for earlier years than 2015, thus the esti-
mates of PLHIV overall and of the proportion of PLHIV 
unaware of their infection could only be calculated for 
2015. 
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New yearly diagnoses of HIV and estimated 
annual HIV incidences
In 2015, 29,727 cases of HIV were diagnosed and 
reported in the EU/EEA, resulting in a rate of 6.3 per 
100,000 population when adjusted for reporting delay. 
The notification rate and the number of new HIV diag-
noses reported have remained unchanged since 2011, 
with between 29,000 and 33,000 new cases reported 
annually (notification rates of between 6.3 and 6.5 per 
100,000 population) [1]. 
HIV incidence estimates present a stable trend similar 
to that of HIV cases notified via the surveillance sys-
tem, with an estimated 30,000 new infections (95% 
confidence interval (CI): 25,000–37,000) for the year 
2015 (Figure 1).
Evolution of CD4 cell count at diagnosis 
and of the delay between infection and 
diagnosis in years up to 2015
Late diagnosis is a persistent issue in EU/EEA coun-
tries. In the 24 EU/EEA countries reporting data on CD4 
cell count at diagnosis among 18,103 persons >15 years-
old diagnosed in 2015, nearly half (n=8,490; 47%) of 
all cases had a CD4 cell count of less than 350 cells/
mm3, while 28% (n=5,094) had advanced HIV infec-
tion (CD4 < 200 cells/mm3). In the thirteen countries 
reporting the CD4 cell count consistently over time, the 
median CD4 cell count at diagnosis increased signifi-
cantly from 314 cells/mm3 in 2005 to 377 cells/mm3 in 
2015 (p < 0.001). 
Meanwhile, the estimated expected time from HIV 
infection to diagnosis decreased from 4.2 years (95% 
CI: 4.1–4.3) on average in 2011 to 3.8 years (95% CI: 
3.6–4.0) in 2015 (Figure 2).
Estimated number of persons living with 
undiagnosed infection
The number of people living with undiagnosed HIV in 
the EU/EEA in 2015 was estimated at 122,000 (95% 
CI: 111,000–136,000). The total estimated number of 
PLHIV in the EU/EEA was 810,000 (0.2% of adult popu-
lation ≥15 years-old). The resulting estimated propor-
tion of those living with undiagnosed HIV was 15% 
(95% CI: 14–17%).
Background and discussion 
The Joint United Nations Programme on HIV/AIDS 
(UNAIDS) has set forth ambitious global targets to end 
AIDS by 2030 and established ‘90–90–90’ targets for 
2020 (90% of all people living with HIV will know their 
status; 90% of people aware of their status will receive 
sustained antiretroviral treatment; and 90% of those 
on antiretroviral treatment will have viral suppression) 
[6]. To better understand HIV trends and estimate the 
status of the first target (90% of people living with 
HIV aware of their status) in the EU/EEA, we analysed 
HIV and AIDS surveillance data through 2015. Despite 
high treatment coverage [7], earlier diagnosis, and con-
certed prevention efforts, there is no decline in the 
number of HIV diagnoses or the number of HIV infec-
tions in the EU/EEA in recent years.
This analysis shows that the estimated proportion of 
all PLHIV in the EU/EEA who are living with undiag-
nosed HIV is 15%. Using a similar CD4 back-calculation 
approach on surveillance data, it was estimated that 
16% of PLHIV in the United States in 2013 were undi-
agnosed [8]. The estimate presented here for the EU/
EEA is considerably lower than the previous estimate 
of 30%, which is based on data from 2005 [9]. This 
could be a result of several factors. First, this might 
be a reflection of increased or more targeted testing 
as supported by the observed increase in the CD4 cell 
counts at diagnosis and decreased time from HIV infec-
tion to diagnosis. With treatment guidelines moving 
towards earlier treatment, and growing awareness of 
the benefits of early antiretroviral treatment, more per-
sons at higher risk of infection may get tested more fre-
quently. Second, the annual number of new infections 
is approximately the same as the number of new diag-
noses. Thus the number living with undiagnosed HIV 
remains relatively stable and as people on treatment 
live longer with HIV, the proportion of undiagnosed 
persons with HIV will naturally become smaller in rela-
tion to the ever-increasing population of diagnosed 
PLHIV [1]. Third, new methods to estimate the undiag-
nosed fraction are available and these are informed by 
improved surveillance data.
While approximately 85% of those living with HIV in the 
EU/EEA are estimated to be diagnosed, it remains to 
be seen whether it is possible for the EU/EEA to reach 
the UNAIDS first ‘90’ target by 2020. A more appropri-
ate measure to gauge progress may be to monitor the 
reduction in the number of undiagnosed individuals 
Figure 1
Estimated human immunodeficiency virus incidence 
by year, European Union/European Economic Area, 
2011–2015
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living with HIV, rather than monitoring a proportion 
where the denominator is steadily increasing.
The average time between HIV infection and diagno-
sis, while improving, is still nearly four years. As start-
ing antiretroviral treatment earlier reduces morbidity 
and mortality among HIV-positive individuals [10] and 
reduces HIV transmission to HIV-negative partners [11] 
it is essential that individuals are diagnosed early. 
In order to further reduce the time from HIV infection 
to diagnosis, countries should consider implement-
ing and scaling up innovative approaches to promote 
greater access to and uptake of HIV testing by those 
most at risk, including community-based testing, self-
testing and home sampling, as well as indicator-condi-
tion-guided testing.
This pooled EU/EEA estimate conceals differences 
between key populations, where the trend over time 
and proportion undiagnosed is likely to vary. An EU 
estimate is also more heavily weighted towards the 
situation of countries with larger populations. The pro-
portion of persons remaining undiagnosed is diverse 
across countries that have carried out national analy-
ses [12-17] and is likely to be significantly higher than 
15% in many countries and among some key population 
groups. In Europe, further work is needed to carry out 
key population-specific and country-level estimates of 
HIV incidence and the undiagnosed number in a stand-
ardised manner in order to more accurately monitor 
progress and inform testing programmes.
This analysis has several important limitations. It was 
not possible to adjust the data for countries that did 
not have full coverage of HIV surveillance prior to 2012 
(such as Italy and Spain) and this may have resulted 
in an underestimation of PLHIV. Conversely, PLHIV 
may have been overestimated due to the inability of 
many countries to fully link their death, emigration and 
surveillance registries and, thus, accurately measure 
the number of those diagnosed still living with HIV. 
For these reasons, it was not possible to obtain a reli-
able estimate of PLHIV using only HIV notification data 
reported to TESSy. Instead, data reported by countries 
through the Dublin Declaration monitoring process on 
people diagnosed and living with HIV were used, and 
these were obtained using different methods, with 
some countries unable to completely remove all cases 
who had died or emigrated from the number diagnosed. 
Until approaches to estimate diagnosed PLHIV can be 
further standardised, country-reported data provide 
the best current estimate in the EU/EEA.
Conclusions
Overall, this analysis demonstrates that recent HIV inci-
dence is constant in the EU/EEA, and that a substan-
tial number of people are living with undiagnosed HIV. 
Efforts to obtain better national and key population-
specific estimates and to further increase the offer and 
uptake of HIV testing among those most at risk remain 
key to informing HIV prevention efforts and achieving 
global targets to reduce HIV incidence and the number 
of persons remaining undiagnosed in the EU/EEA.
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Figure 2
Average time from infection to diagnosis of human 
immunodeficiency virus by year, European Union/
European Economic Area, 2011–2015
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